Goldman Sachs’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,610,731
Closed -$84.5M 4896
2020
Q3
$84.5M Buy
1,610,731
+677,446
+73% +$35.6M 0.02% 574
2020
Q2
$31.1M Buy
933,285
+69,888
+8% +$2.33M 0.01% 1179
2020
Q1
$23.5M Buy
863,397
+226,916
+36% +$6.17M 0.01% 1235
2019
Q4
$12.6M Buy
636,481
+197,524
+45% +$3.9M ﹤0.01% 1916
2019
Q3
$5.69M Buy
438,957
+4,275
+1% +$55.4K ﹤0.01% 2239
2019
Q2
$5.41M Sell
434,682
-79,323
-15% -$988K ﹤0.01% 2263
2019
Q1
$7.47M Buy
514,005
+211,588
+70% +$3.07M ﹤0.01% 2195
2018
Q4
$3.34M Sell
302,417
-70,298
-19% -$776K ﹤0.01% 2566
2018
Q3
$9.8M Sell
372,715
-113,798
-23% -$2.99M ﹤0.01% 2062
2018
Q2
$9.95M Buy
486,513
+26,660
+6% +$545K ﹤0.01% 2009
2018
Q1
$8.35M Buy
459,853
+181,273
+65% +$3.29M ﹤0.01% 2036
2017
Q4
$3.89M Sell
278,580
-261,269
-48% -$3.64M ﹤0.01% 2456
2017
Q3
$9.99M Sell
539,849
-229,254
-30% -$4.24M ﹤0.01% 1973
2017
Q2
$13M Buy
769,103
+274,704
+56% +$4.64M ﹤0.01% 1794
2017
Q1
$6.6M Buy
494,399
+148,092
+43% +$1.98M ﹤0.01% 2050
2016
Q4
$5.21M Buy
346,307
+39,905
+13% +$601K ﹤0.01% 2164
2016
Q3
$3.58M Buy
306,402
+216,914
+242% +$2.54M ﹤0.01% 2418
2016
Q2
$967K Sell
89,488
-21,904
-20% -$237K ﹤0.01% 2953
2016
Q1
$1.03M Sell
111,392
-544
-0.5% -$5.03K ﹤0.01% 2855
2015
Q4
$1.66M Sell
111,936
-71,366
-39% -$1.06M ﹤0.01% 2615
2015
Q3
$3.01M Sell
183,302
-58,215
-24% -$955K ﹤0.01% 2308
2015
Q2
$5.51M Buy
241,517
+3,184
+1% +$72.6K ﹤0.01% 2017
2015
Q1
$3.62M Buy
238,333
+16,021
+7% +$244K ﹤0.01% 2200
2014
Q4
$2.68M Sell
222,312
-85,860
-28% -$1.03M ﹤0.01% 2336
2014
Q3
$3.49M Sell
308,172
-14,727
-5% -$167K ﹤0.01% 2188
2014
Q2
$3.9M Buy
322,899
+94,972
+42% +$1.15M ﹤0.01% 2153
2014
Q1
$2.66M Buy
227,927
+5,135
+2% +$59.8K ﹤0.01% 2388
2013
Q4
$3.94M Sell
222,792
-266,162
-54% -$4.71M ﹤0.01% 2167
2013
Q3
$7.04M Buy
488,954
+43,246
+10% +$622K ﹤0.01% 1686
2013
Q2
$6.71M Buy
+445,708
New +$6.71M ﹤0.01% 1590